Authors: L Bazzichi T Giuliano A Rossi A Mazzoni T Grazzini F De Feo C Giacomelli F Scatena S Bombardieri
Publish Date: 2007/08/08
Volume: 28, Issue: 3, Pages: 295-297
Abstract
We report on a female case of rheumatoid arthritis RA with hepatitis C virus comorbidity The patient was treated once weekly over ten consecutive weeks with Adacolumn® device Clinical assessment and HCVRNA concentration were monitored at weeks—1 4 9 14 and during followup over 6 months At the end of the treatment the number of tender and swollen joints patient’s global assessment of disease activity VAS physician’s VAS Creactive protein CRP decreased respectively ACR response was 20 This improvement was maintained for over 2 months At week 38 the patient was retreated achieving again an ACR response 20
Keywords: